# Pfizer Raises 2026 Outlook After Q3 Results Beat Estimates

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/47735
Published: 2026-11-03T14:01:16.000Z
Updated: 2026-11-03T14:01:16.000Z
Section: Business

> Non-GAAP earnings reached 87 cents per share, and revenue totaled $16.58 billion. Pfizer also named Cecile Guegan chief financial officer.

Pfizer lifted its 2026 outlook after third-quarter earnings and revenue exceeded analyst projections. The company also appointed Cecile Guegan chief financial officer.

Non-GAAP earnings reached 87 cents per share, 14 cents above estimates. Revenue totaled $16.58 billion, topping forecasts by $700 million.

Before the release, analysts had projected earnings of 73 cents per share and revenue of $15.88 billion in the [pre-report estimates](<https://www.tokenpost.com/news/business/46816>).



## Links in this article

- [pre-report estimates](https://www.tokenpost.com/news/business/46816)
